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Abstract. Temperature-sensitive mutations in the 
SEC16 gene of Saccharomyces cerevisiae block budding 
of transport vesicles from the ER. SEC16 was cloned by 
complementation of the sec16-1  mutation and encodes 
a 240-kD protein located in the insoluble, particulate 
component of cell lysates. Secl6p is released from this 
particulate fraction by high salt, but not by nonionic de- 
tergents or urea. Some Secl6p is localized to the ER by 
immunofluorescence microscopy. Membrane-associ- 
ated Secl6p is incorporated into transport vesicles de- 
rived from the ER that are formed in an in vitro vesicle 
budding reaction. Secl6p binds to Sec23p, a COPII ves- 
icle coat protein, as shown by the two-hybrid interac- 
tion assay and affinity studies in cell extracts. These 
findings indicate that Secl6p associates with Sec23p as 
part of the transport vesicle coat structure. 
Genetic analysis of SEC16 identifies three function- 
ally distinguishable domains. One domain is defined by 
the five temperature-sensitive mutations clustered in 
the middle of SEC16. Each of these mutations can be 
complemented by the central domain of SEC16 ex- 
pressed alone. The stoichiometry of Secl6p is critical 
for secretory function since overexpression of Secl6p 
causes a lethal secretion defect. This lethal function 
maps to the NH2-terminus of the protein, defining a 
second functional domain. A  separate function for the 
COOH-terminal domain of Secl6p is shown by its abil- 
ity to bind Sec23p. Together, these results suggest that 
Secl6p engages in multiple protein-protein interac- 
tions both on the ER membrane and as part of the coat 
of a completed vesicle. 
T 
RANSPORT vesicles mediate the movement of pro- 
tein cargo between the organelles of the secretory 
pathway (Palade,  1975).  The yeast Saccharomyces 
cerevisiae  has been useful for identifying genes required 
for the proper function of these transport vesicles. Through 
the use of genetic screens and purification of proteins ac- 
tive in cell-free transport assays, ~20 yeast gene products 
have been identified that act in vesicle transport between 
the ER and Golgi apparatus (for review see Pryer et al., 
1992). Some of these gene products appear to be evolu- 
tionarily  conserved  since  mammalian  homologues  have 
been isolated that have been shown to complement SEC 
gene function or to be located in the transitional region 
between the ER and Golgi apparatus in mammalian cells 
(Wilson et al.,  1989;  Orci et al.,  1991;  Griff et al.,  1992; 
Hosobuchi et al., 1992; Kuge et al., 1994; Shaywitz et al., 
1995). 
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Four genes, SEC12, SEC13, SEC16, and SEC23, are rec- 
ognized to be required for the process of vesicle formation 
from the ER by morphological assays (Kaiser and Schek- 
man,  1990).  SEC16, the least well characterized member 
of this group of genes, was identified in a screen for condi- 
tional mutants  that block secretory protein transport  to 
the cell surface (Novick et al., 1980). At the nonpermissive 
temperature, sec16 mutations cause rapid accumulation of 
secretory  protein  precursors  in  core-glycosylated  ER 
forms showing that Secl6p is needed for protein transport 
to the Golgi apparatus (Novick et al., 1981; Stevens et al., 
1982). SEC16 was implicated in the process of vesicle bud- 
ding since mutants do not form 50-nm transport vesicles 
observed by thin section electron microscopy (Kaiser and 
Schekman, 1990).  The other genes with a similar pheno- 
type, SEC12, SEC13, and SEC23, have been shown to be 
necessary for vesicle budding in cell-free extracts (Rexach 
and Schekman, 1991; Hicke et al., 1992; Pryer et al., 1993). 
SEC13 and SEC23 encode components of the COPII pro- 
tein coat of ER vesicles formed in vitro (Barlowe et al., 
1994). 
Additional evidence for the  involvement of SEC16 in 
vesicle budding comes from the genetic interactions be- 
tween SEC16 and  genes required for vesicle formation. 
sec16-1 or sec16-2 alleles are lethal at 25°C when combined 
with mutations in SEC12, SEC13, or SEC23, but have no 
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later  in  the  secretory pathway  (Kaiser  and  Schekman, 
1990).  These stage-specific genetic interactions show that 
at 25°C,  sEcl6 alleles impair vesicle formation at the ER. 
Further, secl6 mutations are partially suppressed by over- 
expression of SAR1, a small GTP-binding protein that is 
required for ER to Golgi transport  (Nakano and Mura- 
matsu, 1989). The functions of SAR1, SEC12, and SEC23 
constitute a GTP hydrolysis cycle coupled to vesicle for- 
mation. Sec23p stimulates GTPase activity of Sarlp (Yoshi- 
hisa et al., 1993), and Sec12p stimulates exchange of GTP 
for GDP by Sarlp (Barlowe and Schekman, 1993). The ge- 
netic interactions outlined above suggest that the function 
of SEC16 may also relate to this  GTPase cycle. Sec16p 
could generate a local signal that acts on the Sarlp GT- 
Pase cycle; alternatively Sec16p could be acted upon by a 
signal generated by Sarlp. 
In this paper, we describe the isolation of SEC16 and the 
characterization of its  product.  Sec16p was  found to be 
both on the ER and on vesicles that had budded from the 
ER. Moreover, the COOH-terminal domain of Sec16p is 
shown to bind to Sec23p, indicating that Sec16p is part of 
the vesicle coat structure and may serve as a platform for 
incorporation of cytosolic proteins into the vesicle coat. A 
genetic dissection of SEC16 identifies at least three func- 
tionally distinguishable  domains of the protein. Analysis 
of Sec16p  and its  association with  other vesicle compo- 
nents will likely uncover many of the subunit interactions 
that are important for transport vesicle assembly and in- 
tegrity. 
Materials and Methods 
Strains, Media, and Recombinant DNA Techniques 
Table I lists the S.  cerevisiae strains and Table II describes the plasmids 
used in this study. Standard genetic manipulations and yeast transforma- 
tions were performed as described (Kaiser et al., 1994).  Unless otherwise 
noted, cultures were grown in synthetic complete (SC) medium with the 
indicated carbon source and without the supplements appropriate for se- 
lection. DNA manipulations were performed using standard techniques 
(Sambrook et al., 1989).  PCR was performed using Taq polymerase ac- 
cording to the manufacturer's specifications (Perkin-Elmer Cetus, Nor- 
walk, CT). 
Cloning and Sequencing of SECI6 and 
SEC16 Mutations 
SEC16 was isolated from a library of S. cerevisiae genomic sequences in 
YCp50  (Rose et  al.,  1987).  Insert sequences from a  plasmid that com- 
plemented secl6-1  were  subcloned into  the  centromere,  URA3  vector 
pRS316  (Sikorski and Hieter,  1989).  The smallest complementing sub- 
clone contained a 7.2-kb BamHI-SphI genomic fragment. Deletion deriv- 
atives were produced by digestion of linear plasmid DNA with exonu- 
clease III and $1 (Henikoff, 1987). Using nested deletions from both ends 
of the cloned DNA as the templates, the gene was sequenced following 
the protocol  for  the  Sequenase kit  (United  States  Biochemical Corp., 
Cleveland, OH). Gaps in the sequence were filled using synthetic oligonu- 
cleotide primers that matched the sequence of the first strand. 
To test for linkage between the cloned sequences and the SEC16 locus, 
the integrating plasmid YIp352 (Hill et al., 1986)  with a SphI-StuI frag- 
ment containing ~  the COOH-terminal two-thirds of SEC16 was directed 
to integrate at the homologous chromosomal locus by cleaving the plus- 
mid in the insert sequences with PstI  before  transformation of CKY8. 
Two transformants were crossed to CKY51 and tetrads showed complete 
linkage of the plasmid sequences to secl6-2. 
Because the NH2-terminal domain of SEC16 is not essential, we per- 
Table L Saccharomyces cerevisiae Strains 
Strain  Genotype  Source 
CKY8  MATa ura3-52 leu2-3, 112  Kaiser Lab Collection 
CKY10  MATa ura3-52 leu2-3, 112  Kaiser Lab Collection 
CKY19  MATa/MATeL ura3-52/ura3-52 leu2-A1/leu2-A1  Kaiser Lab Collection 
his3-A2OO/his3-A200 ade2-101/ade2-101 
lys2-801/lys2-801 trpl-A63/trpl-A63 
CKY50  MATa secl6-2 ura3-52 his4-619  Kaiser Lab Collection 
CKY51  MATa secl6-2 ura3-52  Kaiser Lab Collection 
CKY52  MATa secl6-1 ura3-52 leu2-3, 112  Kaiser Lab Collection 
CKY93  MATa ura3-52 leu2-3, 112 pep4::URA3  Kaiser Lab Collection 
CKY96  MATa ura3-52 leu2-3, 112 his4-619 Gal +  Kaiser Lab Collection 
CKY107  MATa secl6-3 ura3-52 leu2-3, 112  Kaiser Lab Collection 
CKY200  MATa secl6-2 ura3-52 leu2-3, 112 his4-619 Gal +  Kaiser Lab Collection 
CKY230  MATa secl6-4 secl3-1 ura3-52 leu2-3, 112  K. Roberg and C. A. Kaiser, unpublished data 
ade2 ade3 (pKR4) 
CKY231  MATa secl6-5 secl3-1 ura3-52 leu2-3, 112  K. Roberg and C. A. Kaiser, unpublished data 
ade2 ade3 (pKR4) 
CKY232  CKY96 (pPE4)  This study 
CKY  233  MA Ta/MA Ta SEC16/sec  16- A1:: TRP 1 ura3-5  2/ura3- 52  This study 
leu2-A1/leu2-A1 his3-A2OO/his3-A200 ade2-101/ade2-101 
lys2-801/lys2-801 trp1-A63/trp1-A63 
CKY237  MATa secl6-AI::TRPI  ura3-52 leu2 trp1-A63 Gal + (pPE4)  This study 
CKY238  CKY 10 (pPE8)  This study 
CKY239  CKY10 (pPE26)  This study 
CKY240  CKY96 (pRS315)  This study 
CKY241  MATa/MATa ura3-52/ura3-52 leu2-3, 112/1eu2-3,  112  This study 
HIS4/his4-619 Gal ÷ (pPE4) 
CKY247  CKY237 (pCD43)  This study 
CKY282  MATa ura3-52 leu2-3, 112 his4-619 Gal ÷  This study 
CKY283  CKY93 (pPE26)  This study 
EGY40  MATa ura3-52 leu2 his3 trpl  Golemis and Brent, 1992 
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Plasmid  Description  Source 
pRS304  integrating vector marked with TRP1  Sikorski and Hieter, 1989 
pRS315  centromere vector marked with LEU2  Sikorski and Hieter, 1989 
pRS316  centromere vector marked with URA3  Sikorski and Hieter, 1989 
YCp50  centromere vector marked with URA3  Rose et al., 1987 
YEp352  2p. vector marked with URA3  Hill et al., 1986 
pCD43  GAL1/GALIO promoter in pRS316  Shaywitz et al., 1995 
pPE4  GALl promoted SEC16 in pRS315  This study 
pPE8  SEC16 in pRS315  This study 
pPE26  SEC16-HA  in pRS315  This study 
pPE38  GALl promoted SEC16(565-2194)  in pRS315  This study 
pPE46  GALl promoted SEC16(1017-2194)  in pRS315  This study 
pPE 113  SEC16 disruption in pRS304  This study 
pPE129  SEC16(565-2194)  in YEp352  This study 
pPE 130  SEC16(565-2164)  in YEp352  This study 
pPE131  SEC16(565-1475)  in YEp352  This study 
pPE 132  SEC16(565-1171)  in YEp352  This study 
pPE133  SEC16(565-1027)  in YEp352  This study 
pCK1615  SEC16(565-2194)  in YEp352  This study 
pKR4  SEC13 and ADE3 in pRS315  K. Roberg, and C. A. Kaiser, unpublished data 
pPE12  SUC2 fusion vector marked with URA3  This study 
pPE14  GALl promoted SEC16(1-103)-SUC2  in pRS316  This study 
pPE27  GALl promoted SEC16(1-661)-SUC2  in pRS316  This study 
pPE29  GALl promoted SEC16( I-1092)-SUC2  in pRS316  This study 
pPE30  GALl promoted SEC16(1-1967)-SUC2  in pRS316  This study 
pPE36  GALl promoted SECI 6( 1-499)-SUC2 in pRS316  This study 
pPE37  GALl promoted SEC16(I-824)-SUC2 in pRS316  This study 
pPE53  GALl promoted SEC16(565-1235)-SUC2  in pRS316  This study 
pEG202  lexA DNA binding domain in a 2Ix, HIS3-marked  vector  Gyuris et al., 1993 
pJG4-5  acidic activation domain in a 2ix, TRPl-marked vector  Gyuris et al., 1993 
pSH 18-34  lacZ reporter gene in a 2ix, URA3-marked vector  Gyuris et al., 1993 
pPE58  SEC16( 1645-2194) in pEG202  This study 
pPE59  SEC16(1-824)  in pEG202  This study 
pPE74  SEC16(447-1737)  in pEG202  This study 
pPE81  SEC23 in pJG4-5  This study 
pPE86  GALl-promoted SEC16C-HA(1638-2194)  in pRS315  This study 
pPE 119  GALl-promoted GST-SEC23 fusion in pRS316  This study 
pRD56  GALl-promoted GST in pRS316  R. Deshaies 
The numbers in parentheses indicate the amino acid numbers of the preceding gene's product. 
formed several tests to  establish that the putative initiation ATG pre- 
ceded by in-frame stop codons was in fact the start of translation. First, a 
frame-shift mutation was generated by a 2-bp deletion at a SaclI site at the 
codon for amino acid 103. A clone with this mutation did not complement 
a secl6-2 mutation, indicating that the SaclI site was within the SEC16 
coding sequence. Second, a fusion to the GALl promoter was constructed 
to initiate translation at the putative initiation ATG (pPE4). This plasmid 
was shown to express functional SEC16 by complementation of a chromo- 
somal deletion of SECI6. To show that SEC16 expressed from the GALl 
promoter initiated at the wild-type initiation codon, both wild-type SEC16 
and SEC16 expressed from the GALl promoter were fused at amino acid 
103 to the SUC2 gene. The size of fusion proteins expressed from the wild- 
type promoter and the GALl promoter were identical as determined by 
SDS-PAGE  and  Western  blotting  with  anti-invertase  antibodies  (not 
shown). 
Five temperature-sensitive secl6 mutations were  mapped by marker 
rescue recombination with plasmid-borne SEC16 sequences (Falco et al., 
1983).  A  secl6 mutation to be mapped was transformed with each of a 
nested set of deletion plasmids. To stimulate mitotic recombination be- 
tween the plasmid sequences and chromosomal SEC16, transformant cul- 
tures were exposed briefly to light from germicidal lamps such that ~50% 
of the cells survived. Temperature-resistant recombinants, scored after 
plating at 37°C, arose only if the deletion did not remove the site of the 
mutation. 
Once  located  by  deletion  mapping, each  of the  mutant  alleles was 
cloned by gap repair  of plasmid pCK1615 containing a  gap within the 
SEC16 sequences produced by cutting with XbaI and BstXI before trans- 
formation (Rothstein, 1991).  The base changes responsible for the muta- 
tions were obtained by sequencing the appropriate deletion interval using 
synthetic oligonucleotide primers. 
SECI6 Deletion 
A chromosomal deletion secl6-AI::TRP1  that replaced all but the first 103 
amino acids of SEC16  coding  sequence with  TRP1  was  made by the 
method of ~ transformation (Sikorski and Hieter, 1989).  The disruption 
plasmid, pPE113, contained both a 0.4-kb KpnI~tuI fragment from the 3' 
noncoding  sequence  and  a  BamHI-SacII  fragment  containing  5'  se- 
quences and the first 103 codons inserted into pRS304 (TRP1). A  trpl dip- 
loid, CKY19, was transformed with linearized pPE113 to yield CKY233 
with  a  heterozygous chromosomal disruption of SEC16 that extended 
from amino acid 103 to 30 basepairs past the end of the gene. Integration 
was confirmed by Southern blot analysis (ECL kit; Amersham Corp., Ar- 
lington Heights, IL). 
Construction of GAL Promoter Fusions 
SEC16 was fused to the GALl promoter in pCD43 (Shaywitz et al., 1995) us- 
ing the primer 5'-GCGGATCCAAGAATGACACC]?GAAGCCAAG-3' 
and PCR to create a junction between the BamHI site (underlined) adja- 
cent to the GALl promoter and the beginning of the SEC16 coding se- 
quence (bold). The plasmid expressing full-length SEC16 from the GALl 
promoter, pPE4, contained the complete coding sequence of SEC16 ex- 
tending to the StuI site in the 3'  noncoding sequence inserted into the 
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moter fusion, pPE38, that contained amino acids 565-2194 of Secl6p was 
made  using  the  primer  5'-GCGGATCCAACCATGCGTCAAGAG- 
CAAGTrC-3' to create the junction between an ATG codon at position 
565 and the BamHI site adjacent to the GALl promoter. A  third GALl 
promoter fusion, pPE46, that contained amino acids 1017-2194 of Sec16p 
was  made  using  the  primer  5'-TI"GGATCCATGATTTCATCAAG- 
CATTGTAC-3' to create the junction between an ATG codon at position 
1017 and the BamHl site adjacent to the GALl promoter. 
Construction of  Invertase Fusions 
A  plasmid pPE12 was created to fuse portions of SEC16 to the cytoplas- 
mic form of invertase, encoded by SUC2.  The plasmid pPE12  has the 
XhoI-SacII  polylinker  of pBluescript  (Stratagene  Inc.,  La  JoUa,  CA) 
fused to  SUC2  by use of the following oligonucleotide primer: 5'-TC- 
CCCGCGGCATCAATGACAAACGAAAC-3'.  The SacII site is under- 
lined and the ATG for the internal form of invertase is in bold face. All of 
the SEC16-SUC2 fusions were expressed from the GALl promoter and 
Table II lists the amino acids of SEC16 contained in each fusion. 
Epitope Tagging of SE  C16 
The epitope-tagged SEC16-HA was constructed as follows: a 2-kb PstI- 
NotI fragment of pPE4 was subcloned into pBluescript-SK+ (Stratagene 
Inc.). Oligonucleotide site-directed mutagenesis was used to insert a NotI 
site between amino acids 1892 and 1893 of SEC16 (Kunkel et al., 1987). 
The  oligonucleotide  sequence  was  5'-CATCGCCTGCTATATATG- 
CAGGCGGCCGCAGAACTCACCAAGCACATGC-3'. This  plasmid 
was partially digested with NotI, and a 100-bp NotI-NotI fragment from 
pGTEPI (Tyers et al., 1993),  containing three tandem copies of the he- 
magglutinin epitope recognized by the 12CA5 mAb (BAbCO, Richmond, 
CA), was inserted (Kolodziej and Young, 1991). The epitope-tagged frag- 
ment of SEC16 was inserted into the full-length SEC16 plasmid, pPE8 to 
generate full-length SEC16-HA, pPE26. 
Carboxypeptidase Y (CPY) Immunoprecipitation 
To analyze cells overexpressing Sec16p, a  strain carrying plasmid pPE4 
expressing SEC16  from the  GALl  promoter  (CKY232)  was  grown at 
30°C to exponential phase in minimal medium containing 2%  raffinose 
and 3%  glycerol. Expression from the GALl promoter was induced in 
medium containing 2% galactose for 10 h. To analyze cells with decreased 
levels of Sec16p, a strain with a chromosomal deletion of SEC16 carrying 
pPE4 (CKY247) was grown at 30°C to exponential phase in SC medium 
containing 1% glucose and 1% galactose. Sec16p expression was shut off 
by growth in medium containing 2% glucose for 15 h. The secl6-2 strain 
(CKY50) was grown at 25°C, then 37°C for 1 h. Cultures were labeled for 
10 min at a concentration of ~1 ×  108 cells/ml using 150 ixCi/ml of 35S-radio- 
labeled  cysteine and methionine (Expre  35S35S, DuPont-NEN,  Boston, 
MA). After 10 min, the chase was initiated by addition of cysteine and me- 
thionine to a final concentration of 30 and 40 Ixg/ml, respectively. An ali- 
quot of 2 x  107 cells was removed at time points and lysed using NaOH as 
described below for Western blots. The resulting extract was resuspended 
in 50 ~.1 sample buffer (80 mM Tris-HCl, pH 6.8,  2% SDS, 0.1 M  DTr, 
10%  glycerol, and 0.01%  bromophenol blue) and heated at 95°C for 5 
min. CPY isolated from extracts by immunoprecipitation was analyzed by 
gel electrophoresis and autoradiography (Laemmli, 1970;  Rothblatt and 
Schekman, 1989). 
Electron Microscopy 
CKY50 carrying secl6-2 was grown at 25°C in yeast extract/peptone/dex- 
trose medium (YPD) to exponential phase (N1 ×  107 cells/ml) and shifted 
to 37°C for 1 h. To prepare cells depleted of Secl6p, a strain with a chro- 
mosomal deletion of SEC16  carrying a  plasmid with SEC16  expressed 
from the GALl promoter (CKY237) was grown at 30°C to exponential 
phase in medium containing 1% glucose and 1% galactose, diluted into 
medium containing 2% glucose, and grown for 16 h. Cells were prepared 
for electron microscopy by fixation with glutaraldehyde and KMnO4 (Kai- 
ser  and  Schekman,  1990).  Fixed,  dehydrated  cells were  embedded  in 
Spurr's resin and were sectioned to a thickness of ~70 nm. Sections were 
stained with a 1:5 dilution of Reynold's lead citrate for 2.5 min (Reynolds, 
1963)  to enhance membrane profiles and were viewed in an electron mi- 
croscope (1200CX; JEOL USA, Analytical Instruments Division, Cran- 
ford, N J) at 80 kV. 
Sec  l 6p Antiserum 
Sec16p antiserum was elicited against a hybrid protein composed of a seg- 
ment of Sec16p fused to Staphylococcal  protein A. A  1.4-kb PvulI-PstI 
fragment encoding 460 amino acids from the central region of SEC16 was 
inserted into protein A  fusion vector pRIT31  (Nilsson and Abrahmsen, 
1990). Fusion protein was prepared from Escherichia  coli extracts and an- 
tibody to this protein elicited as previously described (Griff et al., 1992). 
The serum was affinity purified using a 13-galactosidase-Secl6p hybrid 
protein constructed in the vector pEX1 by fusing to lacZ the same PvulI- 
PstI fragment of Secl6p used in the protein A fusion (Stanley and Luzio, 
1984). The hybrid protein was isolated and used for affinity purification of 
the antibody as described (Griff et al., 1992). 
Western Blotting 
Yeast cultures were grown to exponential phase (~1  x  107 cells/ml) in 
YPD or SC medium containing either 2% glucose or, for Sec16p overex- 
pression, 2% raffinose and 3% glycerol followed by growth in 2% galac- 
tose for 4.5 h. Cell extracts were prepared by suspending ~6 ×  107 cells in 
100 t~l medium and adding 17 txl 1.85 M NaOH, 1 M  13-mercaptoethanol 
for  10 min at 4°C (Yaffe and Schatz, 1984).  Proteins were precipitated 
with TCA, washed with acetone, dried, and resuspended in 0.1 ml sample 
buffer by heating to 100°C. Protein extracts were assayed for total protein 
using the DC protein assay (Bio-Rad Laboratories, Hercules, CA). Pro- 
tein samples were separated by electrophoresis on a gel of 6% polyacryl- 
amide, 0.375  M  Tris-HC1, pH 8.8,  0.1%  SDS  without a  stacking layer. 
Electrophoretic transfer of proteins to nitrocellulose was performed in the 
presence of 0.1% SDS (Harlow and Lane, 1988).  Proteins were detected 
using a 1:500 dilution of 12CA5 mouse mAb (BAbCO) and a 1:10,000 di- 
lution of anti-mouse IgG, peroxidase coupled whole antibody from sheep 
(Amersham Corp.),  or  a  1:500  dilution of affinity-purified anti-Sec16p 
rabbit polyclonal antibody and a 1:10,000 dilution of anti-rabbit IgG, per- 
oxidase-linked whole antibody from donkey (Amersham Corp.). Western 
blots  were  developed  using chemiluminescence (ECL  kit;  Amersham 
Corp.). 
Cell Fractionation 
To  analyze  the  subcellular  distribution  of  Sec16p,  a  wild-type  strain 
(CKY10) was grown at 30°C in YPD to exponential phase. 2  x  109 cells 
were suspended in 50 ml 0.1 M  Tris sulfate, pH 9.4, 28 mM 13-mercapto- 
ethanol for 10 min at 25°C, and then spheroplasted for 1 h at 30°C using 
3,700 U lyticase in 10 ml spheroplasting buffer (2% yeast extract, 1% pep- 
tone, 10 mM Tris-HC1, pH 8.0, 0.7 M sorbitol). Metabolic activity was re- 
generated by aeration of spheroplasts in YPD with 0.7 M sorbitol for 1 h 
at 30°C.  Cells were washed in 0.7 M  sorbitol, 0.1  M  NaCI, 10 mM Tris- 
HC1, pH 8.0, 5 mM MgCI2, and gently lysed in 0.5 ml cell lysis buffer (20 
mM MES, pH 6.5, 0.1 M NaCI, 5 mM MgCI2, and protease inhibitor cock- 
tail) using 0.3 g of acid-washed glass beads. The inhibitor cocktail con- 
sisted of I mM PMSF, 10 p.g/ml E-64, 0.5 ~g/ml leupeptin, 0.7 ~g/ml pep- 
statin, 2 ~g/ml aprotinin, and 0.5 U/ml ct2-macroglobulin (all Boehringer 
Mannheim Biochemicals, Indianapolis, IN)  (Jones, 1991).  Cell lysis was 
complete as judged by light microscopy. After lysis, the cell extract was 
subjected to a series of centrifugation steps using an ultracentrifuge rotor 
(TLA100; Beckman Instruments, Palo Alto, CA): 500 g for 20 min; 10,000 g 
for 30 min; and 150,000 g for 60 min, all at 4°C. 
Extraction of Secl6p from the particulate fraction was tested by treat- 
ing 0.1 ml cell extract with 1% Triton X-100, 0.1 M sodium carbonate (pH 
11.5),  2.5 M  urea or 0.5 M  NaC1.  Samples were incubated at 4°C for 1 h 
and separated into soluble and particulate fractions by centrifugation at 
150,000 g for 1 h at 4°C. In both experiments, samples representing equal 
amounts of cell extract were solubilized in sample buffer and analyzed by 
Western blotting as described above. 
Indirect Immunofluorescence 
The intracellular location of Secl6p was examined by indirect immunoflu- 
orescence performed essentially as described (Pringle et al., 1991). A dip- 
loid yeast strain expressing SEC16 from the GALl promoter (CKY241) 
was grown at 30°C to early exponential growth phase (106-107 cells/ml) in 
SC medium containing 2% raffinose and 3% glycerol. To facilitate local- 
ization, Sec16p was overexpressed by transferring the cells to medium 
containing 2% galactose for 2 h before fixation. 
Ceils were fixed for 1 h with 3.7% formaldehyde in the medium. A  10- 
ml culture was collected by centrifugation and then spheroplasted with 
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ethanol for 30 min at 30°C. Antibody incubations were performed on cov- 
erslips in a humid chamber at 25°C for 1 h. Sec16p was detected using a 1: 
100  dilution of affinity-purified See16p antibody and a  1:500  dilution of 
anti-rabbit  Ig-FITC  antibody  (Boehringer  Mannheim  Biochemicals). 
Samples  mounted  in  medium containing  4,6-diamidino-2-phenylindole 
(DAPI) and p-phenylenediamine were photographed with an axioscope 
(Carl Zeiss, Inc., Thornwood, NY) using hypersensitized Technical Pan 
Film 2415 (Lumicon, Livermore, CA) at ASA400 and developed using 
D-19 (Eastman Kodak Co., Rochester, NY) for 4 min at 23°C (Schulze 
and Kirschner, 1986). 
In Vitro Vesicle Synthesis and Purification 
Membranes and cytosol used in the vesicle synthesis reaction were pre- 
pared as previously described with the exception that donor membranes 
were  collected  at  12,000  g  (Wuestehube and  Schekman,  1992).  Mem- 
branes from CKY283 were prepared from spheroplasts that were lysed 
gently with glass beads in the presence of protease inhibitors. Cytosol was 
prepared  from  CKY93  without  added  guanine  nucleotide.  Guanine 
nucleotides were later added as indicated to budding reactions at a final 
concentration of 0.1  mM. A  standard vesicle synthesis reaction of 1 ml 
contained 200 Ixg membranes, 2.4 mg cytosol, 1 mM GDP-mannose, 0.1 
mM guanine nucleotide,  and  an  ATP regeneration system in reaction 
buffer (20 mM Hepes-KOH, pH 6.8, 150 mM KOAe, 5 mM MgOAc, 250 
mM sorbitol) with protease inhibitors (Wuestehube and Sehekman, 1992). 
The reaction with apyrase added contained 10 U/ml apyrase in the place 
of the ATP regeneration system. Reactions were incubated at 20°C for 2 h 
unless otherwise noted. Donor membranes were removed by centrifuga- 
tion of Eppendorf tubes at 17,000 rpm (12,000 g) for 10 min at 4°C in a 
rotor (TLA 100.3; Beckman Instruments, Inc., Palo Alto, CA). Vesicles 
were collected from the supernatant by centrifugation at 60,000 rpm for 30 
min at 4°C in a  TLA 100.3.  Vesicle pellets were  solubilized in sample 
buffer and proteins were analyzed by Western blotting using either the 
12CA5 mAb, a 1:1,000 dilution of Sec22p polyclonal antibody (gift of Dr. 
Charles Barlowe, Dartmouth Medical School, Hanover, NH), or a 1:1,000 
dilution of Sec61p polyclonal antibody (gift of Dr. Randy Schekman, Uni- 
versity of California, Berkeley, Berkeley, CA). Protein detected by West- 
ern blotting was quantitated by densitometry using an Ultroscan (2202; 
LKB Instruments, Inc., Gaithersburg, MD). The protease inhibitor cock- 
tail used for these experiments contained 1 mM PMSF, 10 ~,g/ml E-64, 0.5 
p.g/ml leupeptin, 0.7 }xg/ml pepstatin, 2 i~g/ml aprotinin, 50 ~g/ml antipain, 
1 mg/ml Pefabloc, 0.1 mg/ml phosphoramidon, 40 ixg/ml bestatin, and 0.25 
U/ml a2-macroglobulin (all Boehringer Mannheim Biochemicals). 
Vesicles formed in vitro from donor membranes prepared at 32,000 g 
were fractionated by gel filtration on a  14-ml (18 cm) Sephacryl S-1000 
column (Pharmacia Fine Chemicals, Piscataway, NJ) equilibrated in reac- 
tion buffer as described (Barlowe  et al.,  1994).  A  0.7-ml sample of the 
32,000 g  supernatant from a  1.0-ml reaction was applied to the column, 
eluted with reaction buffer, and 0.75-ml fractions were collected. Vesicles 
in each fraction were concentrated by centrifugation at 60,000 rpm for 30 
min at 4°C in a  TLA 100.3  rotor.  Proteins solubilized in sample buffer 
were analyzed by Western blotting. Column fractions were also assayed 
for total protein using the DC protein assay kit. 
Two-Hybrid Protein-Protein Interaction  Assay 
Potential interactions between Sec16p and Sec23p were investigated using 
the  two-hybrid  protein  interaction  assay  and  the  plasmids  pEG202, 
pJG4-5,  and  pSH18-34  (Gyuris  et  al.,  1993).  Plasmids  derived  from 
pEG202 contained the lexA DNA-binding domain fused to fragments of 
Sec16p:  amino acids 1645-2194 (pPE58),  1-824 (pPE59),  and 447-1737 
(pPE74). The full-length coding sequence of SEC23 was fused to an acidic 
transcriptional activator in the plasmid pJG4-5 to create pPE81. 
Combinations of control or fusion protein plasmids together with a re- 
porter plasmid, pSH18-34, were transformed into the strain EGY40 (Go- 
lemis and Brent, 1992).  Positive interactions were scored as blue colonies 
on SC medium (pH 7.0) containing 2% galactose and 40 mg/1 X-gal. 13-galac- 
tosidase activity was assayed as described  (Kaiser et  al.,  1994).  Strains 
were grown to exponential phase in SC medium containing 2% raffinose 
and 3% glycerol. 10 h before the assay galactose was added to a final con- 
centration of 2% to induce production of the acidic activator protein. Ac- 
tivity was normalized to total protein determined by the Bradford assay 
(Bio-Rad Laboratories). 
Affinity Isolation of Sec  l 6p and Sec23p 
The full-length coding sequence of SEC23 was fused to the glutathione-S- 
transferase (GST) gene (Smith and Johnson, 1988)  expressed from the 
GALl promoter to create pPEll9, a derivative of pRD56 (the kind gift of 
Dr. Ray Deshaies, California Institute of Technology, Pasadena, CA). To 
produce a soluble and detectable COOH-terminal domain of SEC16, we 
used plasmid pPE86 that expressed the COOH-terminus of Sec16p-HA 
(amino acids 1638-2194), from the GALl promoter. Binding was tested in 
extracts from CKY282 transformed with pPE119 and pPE86. 
Protein extracts were prepared from cells grown to exponential phase 
in SC medium, then for 4 h in SC medium containing 2% galactose. 108 
cells were lysed using glass beads in extraction buffer (20 mM Hepes- 
KOH, pH 6.8,  80 mM KOAc, 5 mM MgOAc, 0.02% Triton X-100) with 
protease inhibitor cocktail. The extract was diluted to 1 ml with extraction 
buffer and the lysate was cleared by centrifugation at 13,000 g for 2 min. 
Glutathione Sepharose 4B beads (Pharmacia Fine Chemicals) were added 
and samples were incubated for 1 h  at 25°C.  Beads were washed three 
times in 1 ml extraction buffer and once in buffer without Triton X-100. 
Proteins were solubilized in sample buffer and resolved by SDS-PAGE on 
a 7% gel. Lysate samples were prepared by adding 5× sample buffer to an 
aliquot of cleared lysate. Proteins were transferred to nitrocellulose and 
Western blots were developed as described above. 
Results 
Isolation and Sequence of SECI6 
A genomic library in the centromere vector YCp50 (Rose 
et al., 1987) was screened for clones that complemented 
sec16-1 at  38°C.  A  complementing 7.2-kb  BamHI-SphI 
fragment was isolated. This segment was shown to contain 
the  authentic SEC16 locus by directing integration of a 
plasmid carrying this fragment to the homologous chro- 
mosomal site, and showing that the integrated plasmid se- 
quences were  tightly linked  to sec16-2 by segregational 
analysis. 
The 7.2-kb complementing fragment was sequenced and 
an open reading frame encoding 2,194  amino  acids was 
found. The predicted amino acid sequence is shown in Fig. 
1 a  and the nucleotide sequence is  available  from Gen- 
bank. SEC16 did not appear to be closely related to other 
genes in the database, but two features of the sequence are 
noteworthy. Overall,  the  sequence was  hydrophilic with 
no obvious signal  sequence or transmembrane  domains, 
suggesting a cytoplasmic protein. In addition, the sequence 
contained three regions with a high density of prolyl and 
glycyl residues and with few charged or hydrophobic resi- 
dues; amino acids 581-1050 (18% P  and G), amino acids 
1501-1800  (15%  P  and  G),  and  amino  acids  2076-2175 
(32% P and G). The other regions of the protein had an 
unusually high density of both basic and acidic residues. 
The domains rich in residues that disrupt secondary struc- 
ture could be extended linkers connecting charge-rich do- 
mains. 
Temperature-sensitive Alleles 
Five recessive temperature-sensitive mutations in SEC16 
have been isolated: sec16-1 and sec16-2 were found in the 
original  screen  for sec  mutations  (Novick  et  al.,  1980), 
sec16-3 was isolated in a more recent screen for secretion 
defective mutants  (Wuestehube,  L.,  and  R.  Schekman, 
personal  communication)  and secl6-4  and  sec16-5 were 
isolated  as  mutations  synthetically  lethal  with  sec13-1 
(Roberg, K., and C. A. Kaiser, unpublished results). Each 
mutation was mapped by in vivo recombination tests with 
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51  NRTESDIASK SDVPPVSSST NISPANETQL EIPDTQELHH KLLNDSDQMD  100 
i01  ITADSNDLPD NSIVEHDSVI TQTKPAMSQE YEETAAHLSS RNPSLDVVAG  150 
151  ELHNNNEHTQ KIAVSAVEED SFNEEEGENH DSIIISSLND ATPSQYNHFL  200 
201  PSDGNLLSPE LSSGDTPTHNVPLGTKDNEI NDDEYCNDKE ISLNANNVLP  250 
251  DELSKEEDER LKLETHVSTE EKKQDIADQE TAENLFTSST EPSENKIRNS  300 
301  GDDTSMLFQD DESDQKVPWE EDVKKDFHNE NTNNTQESAP NTDDRDKGYE  350 
351  GNEALKKSES CTAADERSYS EETSEDIFHG HDKQVVEGQN DFTGKNIENE  400 
401  SQKLMGEGNHKLPLSAEADI IEPGKDIQDQ AEDLFTQSSG DLGEVLPWES  450 
451  TDKNADVTSK SQEKHEDLFA ASGNDEKLPW EVSDGEVSSG KTENSMQTST  500 
501  EKIAEQKFSF LENDDDLLDD DSFLASSEEE DTVPNTDNTTNLTSKPVEEK  550 
551  KASRYKPIFE EEAGMRQEQV HFTNTTGIVT PQQFHGLTKT GLGTPNQQVS  600 
601  VPNIVSPKPP VVKDNRSNFK INEEKKKSDA YDFPLEIISE SSKKGHAKPV  650 
651  AVPTQRFGSG NSFSSLDKPI PQSRKGSNNS NRPPVlPLGT QEPRSSRTNS  700 
701  AISQSPVNYA FPNPYKIQQL QQAPIQSGMP LPNTNIPPPA LKVETTVSAP  750 
751  PIRARGVSNA SVGSSASFGA P/4ATQYGLNN  GVPPVSPYGQ ATINLPTANK  800 
801  YAPVSPTVQQ KQYPSWQNL GASAVNTPNFVKTHRGHTSS ISSYTPNQNE  850 
851  HASRYAPNYQ QSYQVPYTSQ PVGPVAGNSS YQSQTRSSYA VPMMPQAQTS  900 
901  ASIQPHANIQ PPTGILPLAP LRPLDPLQAATNLQPRASNI TAANSLPLAN  950 
951  LPLAENILPE IITHRATSSV APPRQEN~PI KIDNEALLRR QFPIFHWSAA  1000 
i001  NKVVYAVPPI PDQSQYMISS SIVQEIKVTP IDQIIKPNDM LKSFPGPLGS  1050 
1051  AKLKKKDLTK WMETTIKSIS ENESSTDMTI WQLLEMKLND KVNWKNISKL  1100 
1101  LYNSDELLMY LSQPFPNGDM IPNAYRLDIN CQMRVLAFLQ TGNHDEALRL  1150 
1151  ALSKRDYAIA LLVGSLMGKD RWSEVIQKYL YEGFTAGPND QKELAHFLLL  1200 
1201  IFQVFVGNSKMAIKSFYTNN ETSQWASENWKSIVAAVLIN IPENNEDPLL  1250 
1251  IPPVVLEFLI EFGIFLTKKG LTAAASTLFI IGNVPLSNEp VMADSDVIFE  1300 
1301  SIGNMNTFES ILWDEIYEYI FSYDPKFKGF SSILPQKIYH ASLLQEQGLN  1350 
1351  SLGTKYTDYL SSSVRKLPKK DILTINLTRE LSEVASRLSE SNTGWLAKPK  1400 
1401  LSSVWGQLDK SFNKYIGGDD IDALNKKNDK KKVFDGFTPG SSANSSTVDL  1450 
1451  TQTFTPFQAQ VTSQSYVDTT ALLHNAHNVp SHSVLHSKPS NVSKGLVEAN  1500 
1501  LPYTHRIGDS LQGSPQRIHN TQFAAAEPQM ASLRRVRTDQ HTNEKALKSQ  1550 
1551  QILEKKSTAY TPQFGQNHSV PMEKSNSNVP SLFADFPAPP KLGTVPSNYV  1600 
1601  SSPDLVRRES IISTGSEFLP PPKIGVPTKA NSSQGSLMYS PSVEALPIDP  1650 
1651  VVPQVHETGY NDFGNKHSQK SMPEDESHTS HDNSNADQNT LKDSADVTDE  1700 
1701  TMDIEGPGFN DVKNLLPMEP NHQPTSTVNP IQTISDDIQP ILQTNV~O  1750 
1751  TDASKM~SL  PSIENERSSE EQPENISKSA SSAYLPSTGG LSLENRPLTQ  1800 
1801  DENSISETVQ STYLPAGSIS MEAKPISQVQ DVPRNVNNKA SKLVEQHMAP  1850 
1851  PKPKSTDATK MNYSPYVPQS TAASADGDES TILKTSPAIY ARTMQAHASN  1900 
1901  PSQYFPLVNQ ANETASFELS ESTSQAQSNG NVASENRFSp IKKAEVVEKD  1950 
1951  TFQPTIRKAS TNQYRAFKPL ESDADKYNDV IEDESDDDNM STDEAKNRKE  2000 
2001  EKKNVNMKKE TKPSNKDIDD KSNGWFGWLK KDTGDKKVYKAKLGHKNTLY  2050 
2051  YDEKLKRWVN KDATEEEKQK IIESSAPPPP PIVKRKDGGp KTKPRSGPIN  2100 
2101  NSLPPVHATS VIPNNPITGE PLPIKTSPSP TGPNPNNSPS PSSPISRISG  2150 
2151  VNLTSKKANG LDDLLSLAGG PKPASTRRKK KTARGYVNVM DNIQ  2194 
a  nested set of SEC16 deletions  (Falco et al.,  1983).  The 
mutations  were  recovered onto  plasmids  by gap  repair, 
and the  appropriate region of the plasmid clone was se- 
quenced. The five mutations were located near the middle 
of the gene; sec16-1 changed Trp 1230 to Arg, secl6-2 and 
sec16-5 were identical and changed Leu 1088 to Pro, secl6-3 
changed Leu 1083 to Pro, and sec16-4 changed Leu 1058 to 
Ser (see Fig. i  b). 
A  series of SEC16 deletions was constructed on a high 
copy vector to  find  the  regions  of SEC16  necessary for 
complementation of the sec16 alleles. The NH2-terminus 
was not required for complementation since a  truncation 
of SEC16  that  removed  the  first  565  codons  (pPE129) 
complemented all sec16 alleles (Fig. 2). Complementation 
depended  on the truncated  allele being expressed from 
a  2tx  vector  and  transcription  presumably was  initiated 
within vector sequences. Extensive COOH-terminal dele- 
tions partially complemented in the sense that sec16 mu- 
tant strains carrying the truncated allele on a plasmid grew 
slowly at 36°C, whereas strains carrying the vector only did 
not grow at all at this temperature, pPE131  (amino acids 
565-1475) partially complemented both sec16-1 and secl6-2, 
and pPE132 (amino acids 565-1171), which had lost the site 
of the sec16-1  mutation, partially complemented secl6-2, 
but  did not complement sec16-1  (Fig.  2).  This intragenic 
complementation behavior shows that the central domain 
of SEC16 can, by itself, provide some function lost in the 
sec16 mutants,  and  therefore ascribes a  discrete function 
to the central portion of the protein. 
NH2-terminal Domain of SEC16 Is Not Essential 
A  null  allele of SEC16 was constructed by replacing the 
sequences from amino acid 103 to beyond the end of the 
coding sequence  with the  TRP1  gene.  This allele, secl6- 
Ah:TRP1, behaved as a recessive lethal since a heterozy- 
gous diploid  segregated  as  two  viable and  two  dead  as- 
cospores  on  sporulation  and  none  of  the  viable  spore 
clones carried the TRP1 marker. 
The ability of truncated SEC16 to complement tempera- 
ture-sensitive  alleles  suggested  that  parts of SEC16  may 
not be essential. We tested the plasmid-borne truncations 
of SEC16 for the ability to complement secl6-Ah:TRP1 by 
segregational analysis in diploids heterozygous for secl6- 
Ah:TRP1  (Fig.  2).  The NH2-terminus of Sec16p  (amino 
acids 1-564) was not essential since viable segregants car- 
Figure 1.  (a) The predicted amino acid 
sequence  of SEC16.  The SEC16  DNA 
sequence  data are available  from Gen- 
Bank/EMBL/DDBJ  under  accession 
number U23819.  (b)  Domain structure 
of Secl6p and locations  of the ts muta- 
tions.  Hatched  regions  designate  por- 
tions of the protein that are rich in pro- 
line residues.  (c) Restriction map of the 
SEC16  gene  and  the  sec16-Ah:TRP1 
allele. 
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tivity of SEC16  truncations. 
Complementation  of secl6-2 
(CKY200)  and  sec16-1 
(CKY52) by plasmids bear- 
ing different truncations  was 
tested  by  growth  at  36°C. 
Complementation  of  sec16- 
AI::TRP1 at 30°C was tested 
by segregational  analysis of 
diploids heterozygous for the 
SEC16 null allele (CKY233). 
Complementation  of the sec- 
16-ZI1::TRP1  allele by  pPE4 
was assayed by plasmid shuffle on medium containing 1% glucose and 1% galactose and 5-fluoro-orotic acid (Boeke et al., 1984). Plas- 
mids pPE8, pPE26, and pPE4 are low copy, centromere  plasmids. Plasmids pPE129, pPE130, pPE131, pPE132, and pPE133 are high 
copy, 21~ plasmids. Shaded bars and amino acid numbers indicate the portion of SEC16 contained on the plasmid. 
rying pPE129 covering the chromosomal deletion could be 
isolated, pPE130, which has the COOH-termina130 amino 
acids  deleted,  was  also  tested.  No  segregants  carrying 
pPE130 covering the chromosomal deletion were found in 
20 tetrads dissected showing that the COOH-terminus of 
Secl6p was essential. 
Depletion of Sec  l 6p 
To test  whether  loss  of Secl6p resulted  in  a  phenotype 
similar to that of the temperature-sensitive (ts) mutations, 
we examined cells depleted of Sec16p. To do this a gene 
fusion was made that placed the expression of SEC16 un- 
der  control  of the  GALl  promoter.  Full  expression  of 
SEC16 from the GALl promoter on 2% galactose is toxic 
to cells (see below). However, growth on medium contain- 
ing 1% glucose and 1% galactose gave modest expression 
of Secl6p that was not toxic.  A  strain with  GALl  regu- 
lated SEC16 covering secl6-AI::TRP1 on the chromosome 
(CKY247)  allowed  SEC16  expression  to be  shut  off by 
growth in glucose. ER to Golgi transport was measured by 
following the maturation of the vacuolar protease CPY. In 
a  pulse-chase experiment,  the core-glycosylated pl  form 
of the CPY proenzyme in the ER is converted to the p2 
form by further glycosylation in the Golgi apparatus and 
finally is proteolytically processed in the vacuole to give 
the  mature  (m)  form (Fig.  3,  lanes 1-3)  (Stevens  et  al., 
1982).  When  CKY247 grown in  medium containing  1% 
glucose and  1%  galactose was transferred to 2%  glucose 
medium, the cells stopped growing within 15 h. The cessa- 
tion of growth was accompanied by a  complete block in 
the  conversion of CPY from the  pl  to p2 form (Fig.  3, 
lanes 4-6). This defect in ER to Golgi transport is compa- 
rable to that in a secl6-2 mutant at the restrictive tempera- 
ture (Fig. 3, lanes 13-15). 
The  phenotype that  results  from depletion  of Sec16p 
was  examined  more  closely  by  electron  microscopy. 
CKY247 was grown in glucose medium for 16 h to develop 
a secretory block due to depletion of Secl6p. These cells 
were  fixed  and  stained  with  permanganate  to  visualize 
membranes.  The  mutant  cells  accumulated  excess  ER 
membranes to a  similar  degree as that  of sec16-2  at  the 
restrictive  temperature  (Fig.  4,  b  and  c).  Importantly, 
there  was  no accumulation of 40-50  nm vesicles  as  ob- 
served in mutants defective in vesicle fusion such as secl7 
and sec18 (Kaiser and Schekman, 1990). Thus, like the ts 
alleles  of SEC16,  depletion  of Secl6p  appears  to  block 
vesicle budding. 
Secl6p Is Lethal When Overexpressed 
We found that a  high copy, 2Ix plasmid carrying SEC16 
transformed yeast at a very low frequency, suggesting that 
overexpression of Sec16p was toxic to cells.  The effect of 
SEC16 overexpression was examined systematically using 
the inducible GALl promoter. A wild-type strain express- 
ing SEC16 from the  GALl  promoter was viable  in me- 
dium containing 2%  glucose, but did not grow in 2%  ga- 
lactose medium. Truncations of SEC16 were used to map 
the portion of the protein responsible for the toxicity on 
Figure 3.  Depletion  or  overexpression 
of SEC16 causes a block in ER to Golgi 
transport.  A  Gal +,  secl6-AI::TRP1 
strain carrying a plasmid with SEC16 ex- 
pressed  from  the  GALl  promoter 
(CKY247) was grown in 1% glucose and 
1% galactose (lanes 1-3) or glucose only 
for 15 h to deplete cells of Secl6p (lanes 
4-6).  A  Gal + strain with a plasmid ex- 
pressing  SEC16  from  the  GALl  pro- 
moter (CKY232) was grown in glucose 
(lanes 7-9) or induced in galactose  for 10 h 
(lanes 10-12). CKY50, a secl6-2 ts strain, was grown at 37°C for 1 h to express a secretion block (lanes 13-15). Cultures were labeled 
with 35S-translabel for 10 min and chased by the addition of excess unlabeled methionine and cysteine for 10 and 30 rain. CPY was im- 
munoprecipitated  from labeled extracts and resolved by SDS-PAGE. The three forms of CPY are labeled pl (ER), p2 (Golgi), and m 
(vacuole). 
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dium of a strain expressing truncations of SEC16 from the 
GALl promoter. Strains expressing the full-length protein 
(pPE4) did not grow on galactose. Removal of amino ac- 
ids  1-564 allowed slow growth on galactose. A  more ex- 
tensive deletion of the NH2-terminus to beyond the  first 
proline-rich  region  allowed  for full  growth  on  galactose 
and placed the toxic domain in the first half of the protein 
(Fig. 5, pPE46). Deletions from the  COOH-terminus us- 
ing SEC16-SUC2 fusions also showed that the toxic por- 
tion of the protein lay in the NH2-terminal domain and did 
not include the region where the point mutations were lo- 
cated  (Fig. 5). Taken together, the behavior of the  trun- 
Figure 4.  SEC16 depletion  causes  accumulation  of ER  mem- 
branes, but not vesicles. (a) Wild-type (CKY8) grown at 25°C and 
shifted to 37°C for 1 h. (b) A sec16-2 ts mutant (CKY50) grown at 
25°C and shifted to 370C for 1 h. (c) A strain deleted for SEC16 
(sec16-Z11::TRP1) carrying a plasmid with SEC16 expressed from 
the GALl promoter (CKY237), grown in glucose for 16 h at 30°C 
to  deplete  cells  of Secl6p.  Cells  were  fixed  and  stained  with 
KMnO4. Bars, 500 nm. 
cated proteins suggested that the first proline-rich region 
was  the  principle  cause  of  lethality  on  overexpression. 
However, a  test of the toxicity of this proline-rich region 
alone  gave  weak  growth  on  galactose,  suggesting  that 
flanking  regions  contribute  to  either  the  toxicity or  the 
conformational stability of this protein domain. 
The  effect of SEC16  overexpression  on  ER  to  Golgi 
transport  was  examined  by following  the  maturation  of 
CPY. After induction of GALl expression of SEC16, CPY 
maturation did not progress beyond the pl form indicating 
a  block in transport to the Golgi apparatus (Fig. 3,  lanes 
10-12). This block was similar to that produced by either 
depletion of Secl6p or a sec16-2 mutation (Fig. 3, lanes 4--6 
and 13-15). 
Since  either  depletion  or  overexpression  of  Secl6p 
blocked  ER  to  Golgi  transport,  the  sec16 ts  mutations 
could act either by reduction or hyperactivation of SEC16 
function.  Reduction  of function  seemed  the  more likely 
possibility  since  the  ts  alleles  were  recessive.  We  per- 
formed an additional explicit test of the mode of action of 
the ts mutations. Each of the four sec16 ts alleles was over- 
expressed from the  GALl promoter and growth was ex- 
amined  at different temperatures. The presence of point 
mutations decreased the toxicity of SEC16, demonstrating 
that  the  mutations  act  by reducing,  not  hyperactivating, 
SEC16 function (data not shown). 
Sec16p Detection 
To study the SEC16 gene product,  we generated  antise- 
rum to a protein containing a 460-amino acid segment in- 
ternal to the SEC16 coding sequence fused to protein A. 
Antibodies specific for Secl6p were affinity purified with 
the internal fragment of Secl6p fused to 13-galactosidase. 
Initial attempts to identify Secl6p on Western blots failed 
because of two unusual properties of the protein. The pro- 
tein was extremely labile in vitro and was completely de- 
graded when cell extracts were prepared by boiling in 2% 
SDS. This proteolysis was eliminated either by lysing the 
ceils with strong alkali or by preparing the extracts in the 
presence  of protease  inhibitors.  Once  stabilized  against 
degradation, the full-length protein did not migrate through 
the  stacking portion  of a  Laemmli gel  (Laemmli, 1970), 
but we found that the protein could be resolved on a 6% 
SDS-polyacrylamide gel  without  a  stacking  layer.  Anti- 
Sec16p antibody recognized a protein that migrated above 
the  190-kD molecular mass marker band (Fig. 6, lane 1). 
The identity of Sec16p was confirmed by showing overpro- 
duction of this protein in a strain expressing Sec16p from 
the GALl promoter (Fig. 6, lane 2). 
A  second method for Secl6p detection used an epitope 
tag. Three tandem copies of the 10-amino acid epitope de- 
rived  from  the  influenza  HA  protein  were  inserted  at 
amino  acid  1892  to  yield  SEC16-HA  (Kolodziej  and 
Young, 1991). SEC16-HA was shown to be fully functional 
by its ability to complement a  null allele (Fig. 2, pPE26). 
The 12CA5 mAb recognized a protein in strains express- 
ing SEC16-HA (Fig. 6, lane 4) with the same mobility as 
the protein detected by Secl6p antiserum. 
The extreme lability of Secl6p in extracts prompted us 
to examine turnover of Secl6p  in  vivo. Cells  expressing 
SEC16-HA were radiolabeled for 10 min with [35S]methio- 
nine and cysteine, and extracts were prepared at times af- 
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domain is lethal  when over- 
expressed.  CKY96,  a  Gal  ÷ 
strain, was tested for the abil- 
ity to grow when expressing 
different  SEC16  gene  frag- 
ments from the  GALl  pro- 
moter on galactose  medium 
at 30°C. + + indicates growth 
indistinguishable from CKY96 
carrying  vector only,  and  - 
indicates  no  growth.  The 
shaded  regions  and  amino 
acid numbers indicate SEC16 
sequences  present in trunca- 
tions  and  the  fusions  to 
SUC2. 
ter addition of unlabeled amino acids. There was no reduc- 
tion  in  labeled  Sec16p  after  a  30-min  chase  (data  not 
shown) showing that the protein is quite stable in vivo. 
The abundance of Sec16p in the cell was estimated by 
two  independent  means  that  gave  similar  results.  First, 
the  invertase  activity produced  in  a  strain  expressing  a 
SEC16-SUC2 fusion protein was used to calculate the cel- 
lular content of fusion protein assuming full specific activ- 
ity of invertase (Goldstein and Lampen, 1975). The gene 
fusion  contained  the  SEC16 promoter plus  the  first  103 
codons of Secl6p carried on a centromere plasmid (pPE14) 
and  was expected to  be expressed  at  approximately the 
same level as endogenous Secl6p. Based on the invertase 
activity, we calculated that there were 104 molecules of the 
hybrid protein per cell. The second method compared the 
intensity  of  bands  on  a  Western  blot  using  a  known 
amount  of bacterially expressed SEC16-lacZ fusion pro- 
tein as a standard. This estimate gave 4 x  103 Secl6p mol- 
ecules per cell by assuming that the full-length protein and 
Figure 6.  Antibody detection 
of Secl6p.  CKY240 (lane 1), 
a  wild-type  strain  carrying 
empty vector,  and  CKY232 
(lane  2)  expressing  SEC16 
from  the  GALl  promoter, 
were  induced  in  galactose 
medium  for  4.5  h  at  30°C. 
CKY238  (lane  3),  carrying 
SEC16  on  a  low  copy plas- 
mid,  and  CKY239  (lane  4), 
carrying SEC16-HA on a low 
copy plasmid, were grown in 
glucose  at  30°C.  Extracts 
were resolved on a 6% SDS- 
polyacrylamide gel without  a 
stacking  layer  and  Secl6p 
was  visualized  by  Western 
blotting.  Lanes 1 and 2 were 
probed  using  affinity-puri- 
fied  anti-Secl6p  antibody. 
Lanes 3  and 4 were probed 
with the 12CA5 mAb recog- 
nizing  the  hemagglutinin 
epitope. 
fusion  protein  were  electrophoretically  transferred  and 
detected with equal efficiency. 
Sec16p Localization 
The antibody to Secl6p was used to examine the intracel- 
lular distribution of the protein. A  cell extract from gently 
lysed  spheroplasts  was  successively  centrifuged  at  500, 
10,000,  and 150,000 g. Secl6p detected by immunoblotting 
was mostly in the  500-g pellet and  the  remainder was in 
the 10,000-g pellet (Fig. 7 a). As a control for cell lysis, the 
cytosolic form of invertase was shown to be present in the 
supernatant after sedimentation at 150,000 g (Carlson and 
Botstein, 1982).  Conditions for release of Secl6p from the 
particulate fractions were tested by chemical treatments of 
the  cell lysate followed by centrifugation at  150,000  g  to 
test for protein released into the soluble fraction (Fig. 7 b). 
Secl6p was not solubilized by nonionic detergents or 2.5 M 
urea, but was partially released into the soluble fraction by 
0.5  M  NaC1 or sodium carbonate (pH 11) (Fig. 7 b). This 
fractionation  behavior was consistent  with  Sec16p  being 
associated with a membrane or the cytoskeleton (Fujiki et 
al., 1982;  Luna and Hitt, 1992).  As a  control for the effi- 
cacy of chemical extraction, the fractionation of the inte- 
gral membrane protein  Secl2p and  the  peripheral mem- 
brane  protein  Sec23p  were  also  followed.  Sec12p  was 
solubilized  by Triton  X-100,  but  not  by the  other  treat- 
ments, and Sec23p was extracted from the particulate frac- 
tion by treatment with sodium carbonate (pH 11), 2.5  M 
urea, and 0.5 M NaC1 (data not shown) (Hicke and Schek- 
man, 1989; Nishikawa and Nakano, 1991). 
The intracellular location of Sec16p was further exam- 
ined by immunofluorescence microscopy. Wild-type cells 
stained  with  affinity-purified  anti-Secl6p  antibody  gave 
very  weak  staining.  Conditions  that  gave  clear  Sec16p 
staining with a minimum of overproduction were found by 
examining  a  diploid  strain  expressing  SEC16  from  the 
GALl promoter (CKY241) 2 h after induction. Many, but 
not all, cells showed concentrated staining at the periph- 
ery of the  DAPI-stained nucleus  (Fig. 8, a  and b).  Since 
perinuclear  staining  is  typical of ER  proteins  (Rose  et 
al.,  1989;  Deshaies  and  Schekman,  1990),  the  pattern  of 
Secl6p  staining was consistent  with  some of the  protein 
being peripherally associated  with  the  membrane of the 
ER. Other cells showed punctate staining dispersed through- 
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and is solubilized by high salt, but not by detergent. (a) A cell ly- 
sate of a wild-type  strain,  CKY10, was subjected  to a series  of 
centrifugation  steps, resulting in 500-, 10,000-, and 150,000-g pel- 
lets (P) and a 150,000-g supernatant (S). An equal number of cell 
equivalents  was loaded in each lane.  (b) Cell lysates were sepa- 
rated into pellet (P) and supernatant (S) fractions by centrifuga- 
tion at 150,000 g after treatment with 1% Triton X-100, 0.1 M so- 
dium carbonate (pH 11.5), 2.5 M urea, or 0.5 M NaC1. Protein 
samples in both a and b were analyzed by SDS-PAGE and West- 
ern blotting using anti-Secl6p antibody. 
out the cell body suggesting that Sec16p was also located 
at sites other than the ER. The observed staining was spe- 
cific for Secl6p because antibody against the HA epitope 
gave similar results with a  strain overexpressing SEC16- 
HA, while no staining was seen in a strain overexpressing 
untagged SEC16. 
Sec  l6p Copurifies with ER to Golgi Transport Vesicles 
Since some Sec16p appeared to be on the ER, we tested 
directly for Sec16p on budded ER to Golgi transport vesi- 
cles produced  in  vitro.  Transport vesicles will  bud  from 
isolated ER membranes in the presence of GTP and cyto- 
sol at 20°C  (Groesch et al., 1990;  Rexach and Schekman, 
1991;  Barlowe  et  al.,  1994).  To  test  for  association  of 
Sec16p with vesicles formed in vitro, partially purified ER 
microsomes isolated from a  strain expressing SEC16-HA 
were incubated with GTP and cytosol at 20°C. Sec16p-HA 
behaved identically to Sec16p in all cell fractionation ex- 
periments,  and  therefore  Sec16p-HA was used  to  facili- 
tate  the  detection  of Sec16p  (data  not  shown).  Because 
Sec16p-HA was insoluble, the only source of Sec16p-HA 
in this reaction was the microsomal fraction. A  crude vesi- 
cle fraction was obtained by removing donor membranes 
from the  reaction by centrifugation  at  12,000  g  and  then 
collecting vesicles by centrifugation  at  100,000  g.  As  ex- 
pected for a vesicle protein, Sec16p-HA entered the vesi- 
cle fraction under conditions that promote vesicle forma- 
tion from the ER; Sec16p-HA was in the vesicle fraction 
when incubated with GTP and cytosol at 20°C, but Sec16p- 
HA in this fraction was greatly reduced when the incuba- 
tion was carried out at 4°C, with apyrase, or without cyto- 
sol (Fig. 9 a). Sec22p, an integral membrane protein that 
resides  in  ER  to  Golgi  transport  vesicles,  served  as  a 
marker for this organelle (Newman et al., 1990;  Lian and 
Ferro-Novick, 1993; Barlowe et al., 1994). The conditions 
for release of Sec16p-HA into  the vesicle fraction paral- 
leled those for Sec22p (Fig. 9 a). Fragmentation of the ER 
was ruled  out  as  a  possible source  of Sec16p-containing 
membranes since the resident ER protein Sec61p was not 
present in this fraction (Fig. 9 a) (Rexach et al., 1994). 
A  more  definitive  test  for  association  of  Sec16p-HA 
with ER to Golgi transport vesicles is to examine whether 
Figure 8.  Immunolocalization of  Sec16p. A  wild-type  diploid 
strain, CKY241, expressing SEC16 from the GALl promoter was 
grown in galactose for 2 h and examined by indirect immunofluo- 
rescence using affinity-purified rabbit anti-Secl6p antibody and a 
fluorescein-conjugated  anti-rabbit secondary antibody.  (a) Fluo- 
rescein-stained  Secl6p.  (b) DAPI-stained nuclear DNA. (c) Cell 
bodies  visualized  by  differential  interference  contrast  (DIC). 
Magnification in top panels: 2,800  ×; bottom panel, 1,750x. 
the vesicles that contain Sec16p-HA behave similarly on 
gel filtration as Sec22p-containing vesicles. It was shown 
previously that vesicles formed in the presence of GMP- 
PNP retain  their  coat of peripheral  membrane proteins, 
whereas those formed in the presence of GTP do not (Bar- 
lowe et al., 1994). In our assay, GMP-PNP and GTP gave 
similar levels of vesicle formation (Fig. 9 a, Sec22p).  We 
chose to use GMP-PNP to produce a  population of vesi- 
cles that were all coated and therefore would display uni- 
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in a reaction using GMP-PNP were separated by gel filtra- 
tion  on  a  Sephacryl  1000  column.  Fractions  were  sedi- 
mented at high speed to collect vesicle pellets which were 
examined for the presence of Secl6p-HA and Sec22p by 
Western  blotting.  Sec22p-containing  vesicles eluted  as  a 
single peak in the  included  volume before the elution of 
most of the total protein (Fig. 9 b). The elution profile for 
Secl6p-HA was identical to that for Sec22p. Thus, Secl6p- 
HA was either associated with the same ER-derived vesi- 
cle population as Sec22p or was associated with other vesi- 
cles that form under the same conditions and were of the 
same size. 
COOH Terminus of Secl6p Binds Sec23p 
The copurification of Sec16p with ER to Golgi transport 
vesicles prompted us to investigate potential protein-pro- 
tein  interactions  between  Sec16p  and  other  recognized 
components of the vesicle coat, using the two-hybrid inter- 
action assay (Fields  and Song,  1989;  Gyuris et al.,  1993). 
Three overlapping fragments of SEC16 (amino acids 1-824, 
447-1737,  and  1645-2194)  were  tested  independently  by 
fusion to a lexA DNA binding domain. SEC23 and SAR1 
each were fused to an acidic activation domain and inter- 
action with each of the SEC16 fragments was tested by as- 
saying activation of transcription of a lacZ reporter gene. 
Strong induction of 13-galactosidase activity was observed 
only when  the  COOH terminus  of Secl6p  (amino acids 
1645-2194) was combined with Sec23p (Table III). This in- 
teraction was shown to  depend  on a  functional  COOH- 
terminal  domain  of SEC16  since  a  parallel  experiment 
conducted  with  a  derivative of the  COOH-terminal  do- 
main that had the last 30 amino acids removed gave no in- 
teraction  (not  shown).  These  results  indicated  that  the 
COOH terminus of Secl6p binds to Sec23p. 
As an independent  test for this  interaction,  binding of 
the COOH terminus of Sec16p to Sec23p was examined in 
yeast  cell  extracts.  The  coding  sequence  of SEC23  was 
fused to GST expressed from the GALl promoter (Smith 
and  Johnson,  1988).  The  COOH  terminus  of  Secl6p 
(amino acids 1638--2194)  containing three copies of the he- 
magglutinin epitope tag (SEC16C-HA) was also expressed 
from the GALl promoter. We found that, unlike the full- 
length Secl6p, a large fraction of the COOH-terminal do- 
main  was soluble  in  cell  extracts,  thus  allowing solution 
binding studies to be performed. Extracts were prepared 
from strains overexpressing Sec16Cp-HA and either GST- 
Sec23p or GST only. Proteins bound to GST-Sec23p were 
isolated on glutathione Sepharose beads, and the presence 
of Secl6Cp-HA was tested by Western blotting with the 
12CA5  mAb. Secl6Cp-HA associated with GST-Sec23p, 
but not GST, demonstrating dependence on Sec23p (Fig. 
10, lanes 1-4).  These experiments demonstrated that the 
COOH  terminus  of  Sec16p  can  form  a  complex  with 
Sec23p in the soluble fraction of cell extracts. 
Discussion 
The SEC16 gene had previously been shown to be one of 
the genes required for the formation of ER transport vesi- 
cles in vivo (Kaiser and Schekman, 1990).  SEC16 interacts 
genetically with SEC23, SEC13, and SAR1, genes whose 
products  are  part  of  a  cytosolic  protein  coat,  termed 
COPII,  that  encapsulates  vesicles  assembled  from  ER 
membranes in vitro (Barlowe et al., 1994). Taken together, 
these results suggested that SEC16 might take part in the 
formation of the COPII vesicle coat. In this report, Sec16p 
finds its place as a  constituent  of COPII-coated vesicles. 
This  conclusion  rests  on  two  findings.  First,  Sec16p  ap- 
pears to be associated with ER-derived vesicles produced 
in an in vitro budding reaction. When membranes bearing 
Sec16p are incubated with cytosol, some of the Sec16p is 
released into a  slowly sedimenting fraction in a  tempera- 
Figure 9.  Secl6p-HA cofractionates  with  ER-derived vesicles. 
(a) Vesicle budding  reactions were performed under the follow- 
ing conditions:  complete reaction at 20°C, complete reaction at 
4°C, reaction with apyrase added, reaction without cytosol, and 
reaction with GMP-PNP instead of GTP. The amount of Secl6p- 
HA, Sec22p, or Sec61p released from the donor membranes into 
the crude vesicle fraction was quantitated  by Western blotting 
and is expressed as a percentage of that protein present in the to- 
tal reaction.  Data shown are the average of two experiments.  (b) 
A  crude vesicle fraction from a budding  reaction performed in 
the  presence  of  GMP-PNP  was  resolved  by gel  filtration  on 
Sephacryl  1000. Membrane pellets were collected  from column 
fractions by centrifugation  and were examined by SDS-PAGE 
and Western blotting. The elution profile of total protein and the 
estimated void (Vo) fractions are shown. 
Table III. Sec23p Interacts with the COOH Terminus of  Secl6p 
by Two-Hybrid Assay 
13-galactosidase activity 
SEC23  no  fusion 
SEC16(aa 1645-2194)  952.9 -  39.0  6.2 +- 2.1 
SEC16(aa 447-1737)  85.4 ±  14.1  12.2 _  3.3 
SEC16(aa 1-824)  10.1  -+ 9.4  6.8 -  1.8 
no fusion  32.9 -  12.6  118.9 +  128.6" 
EGY40  cells  transformed by plasmids  encoding a  lexA  fusion  protein  (pEG202, 
pPE58, pPE59, or pPE74), an activator domain fusion protein (pJG4-5 or pPE81), and 
a reporter plasmid (pSH18-34) were grown in galactose for 10 h before the assay to in- 
duce expression of fusion proteins. Units of I~-galactosidase  activity (nmol/mg ×  rain) 
were calculated as (optical density at 420 nm X vol of assay)I(0.0045 X concentration 
of protein in extract assayed ×  time). Activities shown were the mean _  SD for three 
independent transformants. 
*The three values from this experiment were 20.6, 71.6, and 264.4 units. 
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occurs under conditions that closely parallel the behavior 
of Sec22p, an integral membrane protein marker for ER- 
derived  transport  vesicles.  When  the  material  released 
from ER membranes is subjected to gel filtration, Secl6p 
cofractionates with the Sec22p-containing vesicles. These 
results strongly suggest that Secl6p is coating ER-derived 
vesicles. We cannot rigorously rule out the possibility that 
Secl6p  is  associated  with  vesicles derived  from another 
source, such as the Golgi apparatus. However, if this is the 
case, these other vesicles must form under the same condi- 
tions and have the same gel filtration properties as vesicles 
derived from the ER. The principal difficulty in establish- 
ing  this  point  is  that  we  have  not  yet  found  conditions 
whereby ER-derived vesicles can be affinity purified with 
the COPII coats intact. 
The second finding that indicates Secl6p is part of the 
COPII  coat  is  that  Sec16p  binds  to  the  COPII  protein 
Sec23p.  Initially,  this  interaction  was  detected  using  the 
two-hybrid  transcription  assay when  testing  for interac- 
tions between SEC16 and  the  COPII genes, SEC23 and 
SAR1.  A  strong interaction was only detected for SEC23 
in combination with the COOH-terminal domain of SEC16. 
Binding of these proteins was confirmed by showing that 
the COOH-terminal domain of SEC16 expressed in yeast 
cells is found in protein complexes affinity isolated using a 
GST-Sec23p fusion. The full-length Secl6p was not used 
in these tests because it is so tightly bound to intracellular 
membranes that the protein is not available in cell extracts 
for affinity isolation steps. The simplest interpretation of 
these results is that Sec23p is in physical contact with the 
COOH terminus of Secl6p, however, direct protein-pro- 
tein contact has not been established. It is possible that a 
third protein present in the cytoplasm (and in the nucleus 
for the two-hybrid assay) binds to both Secl6p and Sec23p, 
providing a link between the two proteins. 
ER  membranes that  have been  stripped of peripheral 
proteins by washing with  urea  are  absolutely dependent 
on cytosolic proteins for the formation of transport vesi- 
cles in vitro (Baker et al., 1988;  Salama et al., 1993).  The 
five  purified  COPII  proteins,  Sec23p/Sec24p,  Secl3p/ 
Sec31p, and Sarlp, satisfy the cytosolic requirement,  and 
Figure 10.  Complexes formed between Sec23p and the COOH 
terminus of Sec16p. Lanes 1 and 2:  CKY282, with  both GST- 
SEC23  (pPEll9)  and  SEC16C-HA  (pPE86).  Lanes  3  and  4: 
CKY282, with GST (pRD56) and SEC16C-HA (pPE86). Lanes 5 
and 6: CKY282, with GST-SEC23 (pPEll9) and the empty vec- 
tor (pRS315). Expression of proteins from the GALl promoter 
was induced by growth in galactose for 4 h. Lysates from 107 cells 
were cleared by centrifugation  and proteins bound to glutathione 
Sepharose beads were isolated. Proteins bound to the glutathione 
beads are in lanes 2, 4, and 6. One-tenth of the total lysate was 
loaded in the extract lanes 1, 3, and 5. Secl6Cp-HA was detected 
by SDS-PAGE and Western blot analysis using the 12CA5 mAb. 
these  proteins become components of a  protein  coat  on 
the transport vesicles formed in this reaction (Barlowe et 
al., 1994).  No requirement for exogenously added Secl6p 
has been detected for the vesicle budding reaction, but a 
reason for this is now clear. Whereas other peripheral ER 
proteins, such  as  Secl3p  and  Sec23p  (Hicke and  Schek- 
man, 1989; Pryer et al., 1993), are removed from ER mem- 
branes by washing with urea, we have found that Secl6p is 
not extracted from membranes by this procedure. Thus, to 
the extent that Secl6p is needed for budding in vitro, the 
requirement is presumably satisfied by Secl6p introduced 
into the budding reaction as a component of the donor ER 
membranes. 
Models for transport vesicle budding have emphasized 
the role of vesicle coat proteins partitioned between solu- 
ble and membrane-bound states. The idea is that vesicle 
formation is driven by the  assembly of soluble coat pro- 
teins  onto  the  membrane  (Pearse  and  Robinson,  1990; 
Rothman and Orci, 1992). If Secl6p is such a coat protein, 
the  time  that  it  spends  off the  membrane must  be  very 
brief since there is virtually no solubl  e Secl6p detected in 
cell extracts. When Secl6p is localized using cell fraction- 
ation  and  immunofluorescence,  some of the  protein  ap- 
pears to be associated with the ER. A  simple explanation 
for this behavior is that Sec16p forms a permanent, periph- 
eral membrane coat. The Secl6p that resides on the sur- 
face of the  ER  may be required  to  recruit other vesicle 
coat  components,  such  as  Sec23p,  to  the  sites of vesicle 
budding. 
The finding that overexpression of SEC16 on a 2ix plas- 
mid or from the GALl promoter is lethal and blocks ER 
to Golgi transport suggested that Secl6p could be an in- 
hibitor of vesicle formation. According to this hypothesis, 
the  ts  alleles  could  exert  their  effect by hyperactivating 
the  inhibitory  function.  Two  genetic  experiments  argue 
strongly against this possibility. First, depletion of Secl6p 
by shutting off regulated expression from the GALl pro- 
moter is lethal and causes a secretion block. Thus, SEC16 
performs a positive function in transport and cannot sim- 
ply be an inhibitor.  Second, we tested the effect of muta- 
tions on the toxicity of overexpressed SEC16; if the point 
mutations are hyperactivating, then overexpression of the 
mutant alleles at high temperature should inhibit growth 
more than  wild-type SEC16.  We found that  the  overex- 
pressed ts  alleles  are  less restrictive  than  wild-type,  and 
therefore conclude that the ts alleles antagonize the func- 
tion  of SEC16  that  causes  lethality  on  overproduction. 
Thus, there is a critical stoichiometry for Secl6p, and more 
or less protein causes a lethal secretion defect. This behav- 
ior points to a  structural  role for Sec16p  in  an assembly 
whose subunit composition is critical for function and too 
much or too little Secl6p leads to the assembly of inactive 
complexes. 
The SEC16 sequence  contains  alternating regions that 
are either rich in  charged amino acids or rich  in proline 
and uncharged residues. Clusters of proline residues have 
been observed in synaptic vesicle proteins and have been 
proposed to serve as structural spacers between functional 
domains (Linial,  1994).  Interestingly, our results indicate 
that  Sec16p  is  a  multifunctional  protein,  suggesting that 
the proline-rich regions may serve to connect globular do- 
mains that carry out different functions. 
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separable domains that roughly correspond to the central 
region, NH2-, and the COOH termini of the protein. The 
five  ts mutations are clustered  in a 250-bp region of the 
gene  suggesting  that  the  mutations  may  affect  a  single 
function.  Internal  fragments  of  SEC16  that  contain  the 
central portion of the protein can complement these muta- 
tions.  This  intragenic complementation  behavior  defines 
the central region of the protein as an independent func- 
tional unit. 
We were able to map roughly the portion of the protein 
that causes a lethal secretion block on overexpression by 
testing truncated versions of Secl6p for this lethal effect. 
The critical portion of the protein lies in the NH2-terminal 
region (amino acids  1-824). This part of the protein may 
bind to and thereby deplete  another factor necessary for 
vesicle formation. This second domain, defined by overex- 
pression lethality, extends to the middle of the first pro- 
line-rich region, but does not overlap with the region con- 
taining the point mutations. 
Biochemical and genetic experiments identify the COOH 
terminus  as  a  third  functional  domain  of  Sec16p.  The 
COOH terminus of Secl6p  (amino acids  1643-2194)  and 
Sec23p  interact  in  the  two-hybrid  assay  and  by  binding 
experiments  in  yeast  cell  extracts.  In  the  accompanying 
paper, we show that the cytosolic domain of the ER pro- 
tein Sed4p  also binds to the COOH-terminal  domain of 
Secl6p.  Complementation  experiments  demonstrate  that 
the COOH terminus of SEC16 is essential for the growth 
of a  strain  deleted  for SEC16.  This  requirement  for  the 
COOH terminus may reflect the need for this domain in 
binding to Sec23p, Sed4p, and possibly additional proteins. 
Collectively,  SEC16  functional  studies  indicate  that 
Secl6p  is composed  of a  number  of different  functional 
units. We are now in a position to identify other transport 
factors  that  bind  to  the  different  regions  of  SEC16  by 
affinity purification, genetic suppression screens,  or two- 
hybrid screens. Since Secl6p appears to be part of the ves- 
icle coat, sandwiched between membrane proteins and the 
cytosolic coat proteins, many of the significant subunit in- 
teractions in the vesicle coat structure may be revealed by 
studying proteins associated with SEC16. 
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